Tenaya Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $131,193,000.
Profit Margin
| 2019 | 0 | -25.77M | |
|---|---|---|---|
| 2020 | 0 | -38.30M | |
| 2021 | 0 | -69.65M | |
| 2022 | 0 | -123.66M | |
| 2023 | 0 | -124.08M |
TNYA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 8.68M | 8.71M | 4.02M | 2.48M | 1.98M |
Gross profit | -8.68M | -8.71M | -4.02M | -2.48M | -1.98M |
Operating exp. | |||||
Research and development | 98.03M | 94.53M | 54.39M | 31.09M | 23.14M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 131.19M | 125.62M | 72.80M | 38.91M | 27.71M |
Operating income | -131.19M | -125.62M | -72.80M | -38.91M | -27.71M |
Other income (expenses), net | 7.10M | 1.95M | 85K | 517K | 1.48M |
Income before tax | -124.08M | -123.66M | -72.72M | -38.39M | -26.23M |
Income tax expense | 0 | -1.95K | -3.06M | -87K | -453K |
Net income | -124.08M | -123.66M | -69.65M | -38.30M | -25.77M |
Earnings per share | |||||
Basic EPS | -1.68 | -2.76 | -1.69 | -0.93 | -0.63 |
Diluted EPS | -1.68 | -2.76 | -1.69 | -0.93 | -0.63 |
| Data source | Data source | Data source |